LRRK2 and Parkinson disease: On the other hand, overexpression of α-syn increased LRRK2 kinase activity accompanied by dopaminergic neurodegeneration, while inhibition of LRRK2 attenuated α-syn toxicity in a mouse PD model suggesting bi-directional synergistic regulation between α-syn and LRRK2 [24].